LeMaitre Vascular Stock Forecast for 2023 - 2025 - 2030
Updated on 04/27/2024
LeMaitre Vascular Stock Forecast and Price Target
The average price target for LeMaitre Vascular's stock of $70.00 recently provided by leading analysts would represent a 6.94% upside from its last closing price if reached. This potential increase is based on a high estimate of $84.00 and a low estimate of $59.00. If you're looking to buy LeMaitre Vascular stock, you may also want to check out its rivals.
6.94% Upside
LeMaitre Vascular Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, LeMaitre Vascular's Price has decreased from $40.68 to $0.00 – a 100.00% drop. In the next year, analysts predict that Fair Value will reach $59.49 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ABT Stock Forecast | Abbott Laboratories | Outperform |
9
|
$107.53 | Buy/Sell | $118.92 | 17.64% |
| BSX Stock Forecast | Boston Scientific | Outperform |
11
|
$73.17 | Buy/Sell | $70.14 | 12.07% |
| BDX Stock Forecast | Becton Dickinson and Co | Outperform |
9
|
$231.55 | Buy/Sell | $284.47 | 19.84% |
| 4543 Stock Forecast | Terumo | Outperform |
18
|
¥5.63k | Buy/Sell | ¥4.97k | -9.46% |
| BAX Stock Forecast | Baxter International Inc | Outperform |
17
|
$40.13 | Buy/Sell | $44.86 | 12.14% |
LeMaitre Vascular Revenue Forecast for 2023 - 2025 - 2030
LeMaitre Vascular's Revenue has grown in the last two years, jumping from $129.37M to $161.65M – an increase of 24.95%. In the next year, analysts predict that Revenue will reach $210.01M – an increase of 29.92%. For the next seven years, the forecast is for Revenue to grow by 25.91%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ABMD Stock Forecast | Abiomed | - |
16
|
$377.79 | Buy/Sell | $380.00 | -88.33% |
| SWAV Stock Forecast | Shockwave Medical | Hold |
4
|
$330.00 | Buy/Sell | $239.91 | 1.52% |
| PEN Stock Forecast | Penumbra | Outperform |
9
|
$204.41 | Buy/Sell | $258.62 | 40.43% |
.jpg)
LeMaitre Vascular Dividend per Share Forecast for 2023 - 2025 - 2030
In the last two years, LeMaitre Vascular's Dividend per Share has increased by 31.58%, going from $0.38 to $0.50. 1 analysts predict LeMaitre Vascular's Dividend per Share will decrease by 0.00% in the next year, reaching $0.50. By 2030, professionals predict that LeMaitre Vascular's Dividend per Share will decrease by 6.84%, to $0.47.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| GETI B Stock Forecast | Getinge AB | Outperform |
18
|
kr235.10 | Buy/Sell | kr226.10 | -3.02% |
| MMSI Stock Forecast | Merit Medical Systems | Outperform |
14
|
$73.78 | Buy/Sell | $89.25 | 19.27% |
| AORT Stock Forecast | Artivion | Buy |
12
|
$20.57 | Buy/Sell | $24.15 | 21.54% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SILK Stock Forecast | Silk Road Medical, Inc | Outperform |
7
|
$17.80 | Buy/Sell | $12.33 | 6.74% |
| IRMD Stock Forecast | IRadimed | Buy |
16
|
$41.86 | Buy/Sell | $60.00 | 49.31% |
| UTMD Stock Forecast | Utah Medical Products | - |
18
|
$73.10 | Buy/Sell | $0.00 | -100.00% |
LeMaitre Vascular EBITDA Forecast for 2023 - 2025 - 2030
LeMaitre Vascular's EBITDA has increased by 7.25% In the last two years, going from $36.71M to $39.37M. In the next year, analysts expect EBITDA to reach $56.43M – an increase of 43.33%. For the next seven years, the forecast is for EBITDA to grow by 72.22%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ANGO Stock Forecast | AngioDynamics | Buy |
8
|
$5.81 | Buy/Sell | $16.33 | 123.75% |
| ELUT Stock Forecast | Elutia | Buy |
2
|
$3.94 | Buy/Sell | $0.00 | 26.90% |
| CSII Stock Forecast | Cardiovascular Systems | - |
7
|
$19.86 | Buy/Sell | $20.00 | -100.00% |
LeMaitre Vascular EBIT Forecast for 2023 - 2025 - 2030
In the last two years, LeMaitre Vascular's EBIT has grown, increasing from $28.32M to $29.94M – a growth of 5.72%. The next year looks promising for LeMaitre Vascular, with analysts predicting EBIT of $42.78M – an increase of 42.89%. Over the next seven years, experts anticipate that LeMaitre Vascular's EBIT will grow at a rate of 211.96%.
LeMaitre Vascular EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, LeMaitre Vascular's EPS has decreased from $1.06 to $0.00 – a 100.00% drop. In the next year, analysts predict that EPS will reach $1.55 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.
.jpg)